A multicenter evaluation of the efficacy and duration of action of alcaftadine and olopatadine in the CAC model. http://t.co/OKM2VIiBa3
The efficacy and duration of action of alcaftadine and olopatadine in the conjunctival allergen challenge model http://t.co/lVswJm7T9b
Evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the CAC model http://t.co/DruUXxGzpq
RT @Aller_MD: Efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in conjunctival allergen challenge model http://t.co/qP26Fc7BNP
RT @Aller_MD: Efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in conjunctival allergen challenge model http://t.co/qP26Fc7BNP
RT @Aller_MD: Efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in conjunctival allergen challenge model http://t.co/qP26Fc7BNP
Efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in conjunctival allergen challenge model http://t.co/qP26Fc7BNP